| ABCD |
Association of British Clinical Diabetologists |
| ADA |
American Diabetes Association |
| ADIPS |
Australian Diabetes in Pregnancy Society |
| BMI |
body mass index |
| BNF |
British National Formulary |
| CGM |
continuous glucose monitoring |
| DPP-4 |
dipeptidyl peptidase-4 |
| EBCOG |
European Board and College of Obstetrics and Gynaecology |
| FIGO |
International Federation of Obstetrics and Gynecology |
| FPG |
fasting plasma glucose |
| GDM |
gestational diabetes mellitus |
| GLP-1 |
glucagon-like peptide 1 |
| GMI |
Glucose Management Indicator |
| HAPO |
Hyperglycemia and Adverse Pregnancy Outcomes study |
| HbA1c |
glycated haemoglobin |
| IADPSG |
International Association of Diabetes and Pregnancy Study Groups |
| isCGM |
intermittently-scanned continuous glucose monitoring |
| JDS |
Japan Diabetes Society |
| NICE |
National Institute for Health and Care Excellence |
| OGTT |
oral glucose tolerance test |
| PCOS |
polycystic ovary syndrome |
| rtCGM |
real-time continuous glucose monitoring |
| SIGN |
Scottish Intercollegiate Guidelines Network |
| SGLT2 |
sodium glucose cotransporter 2 |
| T1DM |
type 1 diabetes mellitus |
| T2DM |
type 2 diabetes mellitus |
| TIR |
time in range |
| UK |
United Kingdom |
| WHO |
World Health Organization |
Management of diabetes in pregnancy (SIGN)
